Upload
john-holland
View
214
Download
1
Embed Size (px)
Citation preview
Virus Genes 16:1, 13±21, 1998
# 1998 Kluwer Academic Publishers, Boston. Manufactured in The Netherlands.
Origin and Evolution of Viruses
JOHN HOLLAND1* & ESTEBAN DOMINGO2
1Department of Biology and Center for Molecular Genetics, University of California, San Diego, La Jolla, CA 92093±0116 USAE-Mail: [email protected].
2Centro de Biologia Molecular Severo Ochoa Universidad Autonoma de Madrid, Cantoblanco, 28049 Madrid, SpainE-Mail: [email protected].
Virus Origins
The origin(s) of viruses can not be known with
certainty. PCR and other sensitive molecular techni-
ques will reveal some viral genome sequences from
the relatively recent past, but very ancient viral
genomes will remain a matter for speculation.
Numerous theories have been advanced regarding
virus origins (reviewed in 1) and all necessarily
involve speculation. However, comparative sequence
analysis strongly suggests that both RNA (2) and
DNA (3) viruses have deep, archaic evolutionary
roots both for genome structural organization and as
regards certain genomic and protein domains. It is
also clear that both DNA and RNAviruses can emerge
and evolve by a variety of mechanisms including
mutation, recombination and reassortment. This can
involve point mutation, insertions and deletions,
acquisition or loss of genes (and gene domains, or
sets of genes), rearrangement of genomes and
utilization of alternate reading frames or inverted
reading frames (1±6).
Recombination can create new viruses by cap-
turing genes or gene segments or sets of genes either
from cellular nucleic acids or from other viruses. The
presence of cellular genes within virus genomes has
long been recognized (5). Likewise, the resemblance
of viruses to plasmids, episomes and other mobile
DNA or RNA replicons such as transposons or
retrotransposons is obvious (1,7±9). The only clear
distinction between many such mobile elements and
viruses is the maturation of the latter within capsids
(and envelopes) to affect ef®cient transmission and
target cell receptor speci®city. This is well-illustrated
in the cases of bacteriophage Mu (which is both a
virus and a transposon) and retroviruses (which are
retrotransposons containing a functional envelope
gene). As Temin pointed out (10), non-viral retroid
elements can become retroviruses only when such
retrotransposing protoviruses acquire envelope genes
from another viral or cellular source by recombina-
tion. DNA viruses and (non-retrovirus) RNA
riboviruses may also arise by recombinational (or
reassortment) reshuf¯ing of cellular and viral or
plasmid/episome/transposon mobile element genes.
Botstein (11) theory of modular evolution of DNA
viruses is quite plausible. It envisions virus evolution
by recombinational arrangement of interchangeable
genetic elements or modules. The advantage of such
modular evolution is obvious. It allows virus genes,
protein domains, regulatory systems, etc. to evolve
independently under a wide variety of selective
conditions. Thus, one module might have undergone
its most recent evolution as part of an integrated
episome, another as part of a transposon, a third as a
plasmid element, yet another as part of a cellular gene
or an integrated defective virus, etc. Such modular
mobility obviously can relax evolutionary constraints
which would prevail if all were required to co-evolve
within a single genomic unit. Of course, it will be an
extremely rare event which could bring about a
fortuitous compatible recombination of indepen-
dently-evolving modules to create a new virus
having good biological adaptive capacity. But
signi®cant virus emergences are likewise extremely
rare occurrences and the probabilities for emergence
of a drastically different virus solely by mutational
changes within a single genome are generally orders
of magnitude less probable. Sequence space as
elaborated by Eigen and colleagues (12) has incom-
prehensibly vast dimensions, and distant, previously
unexplored regions of sequence space can best be
reached (and mutationally explored) by the evolu-
tionary leaps which recombination or reassortment
afford. See Kauffman (13) for detailed discussion of
this point. Finally, it should be emphasized that
ordinary RNA viruses (riboviruses), in additional to
DNA viruses and retroviruses, can undergo such
modular evolution via RNA recombination (and
reassortment). The essence of all viruses is obligate
intracellular parasitism coupled with the capacity for
intimate genetic interactions with the DNA and RNA
of their hosts and of cohabiting mobile elements.
The nature of the earliest viruses can never be
determined, but it is likely that they arose very early
during the evolution of life on earth. It seems
extremely likely that elemental life forms involved
RNA replicons (14) and these might have borne
resemblance to present-day RNA replicons such as
viroids, virusoids or viruses. In fact, Robertson (15)
has suggested that very early, primitive autono-
mously-replicating, self-cleaving RNA replicons
akin to present-day viroids might have acquired
additional genes to form conjoined replicons which
later evolved into mosaic DNA-based entities.
Hepatitis D virus was suggested as a present day
example of such a conjoined viroid-like RNA
replicon. It contains an open reading frame encoding
the delta antigen protein joined to the viroid-like
domain. Recently (16), it was shown that liver cells
express a cellular homolog of the delta antigen,
suggesting that hepatitis D virus may have arisen by
the capture of a cellular RNA transcript by a viroid-
like RNA. A copy choice template transfer
mechanism was proposed for the recombinational
capture event. Robertson (15) suggested that such
events occurring early in the primitive RNA world
could later have given rise to mosaic DNA modules,
and might even be responsible for the present
widespread prevalence of split genes and introns and
RNA-catalyzed cleavage and ligation splicing sys-
tems (17). In general, it is quite plausible that not only
viroid-like, but plasmid-like transposon-like, retro-
transposon-like and virus-like autonomously-
replicating RNA and DNA elements (replicons)
have been intimately involved in nearly all evolution
of life on earthÐboth in precellular and cellular eras.
Therefore, it is probable that the origins of viruses
date from great antiquity and continue to the present.
Presently, of course, nearly all new viruses emerge via
evolution of old viruses. This is compatible with the
deep evolutionary trees deduced for both DNA and
RNA viruses (4) and with the long-recognized
capacity of viruses to acquire genetic elements from
host cell nucleic acids and form other mobile
replicons (1).
Virus Evolution
The evolution of existing viruses, as for all living
things, proceeds via a variety of mechanisms
including mutation, recombination, reassortment and
environmental selection. Space limitations prevent
extensive discussion of virus evolution in this short
review, so only major points will be discussed here.
For an excellent recent overview of the molecular
basis of virus evolution, see (4). More concise
coverage is provided in review articles (1,18±22).
RNA Virus Mutation Rates are Very High
It is now clear that all or nearly all RNA viruses have
extremely high mutation rates (18±23). Mutation rates
at individual base sites may vary considerably, but
average nucleotide base misincorporation rates are of
the order of 10ÿ 4 to 10ÿ 5 (reviewed in 21±23). This
results in the generation of quasispecies mutant
swarms even when the virus population has just
arisen from a clone (21,22,24). A clonal quasispecies
virus population is a diverse mixture of virus mutants
differing from each other at one or several genomic
sites, and can be envisioned as a cloud in sequence
space. A consensus sequence will represent the
average sequence at each genome site and the
master sequence(s) represent the most ®t member(s)
of the swarm in any particular de®ned selective
environment. When the selective environment
changes the master sequence(s) and the overall
composition of the quasispecies swarm will also
change.
Obviously, the generation of quasispecies mutant
swarms can provide RNA viruses with great adapt-
ability under conditions in which there is
environmental change, and in complex mammalian
hosts, viruses always encounter changing conditions
(e.g., different cell types, in¯ammatory responses,
14 Holland and Domingo
immune responses, fever temperatures, interferons,
etc.). It should be emphasized that, whereas the most-
adapted master sequence(s) and closely-related var-
iants will be the most abundant and most important
variants under rather constant environmental condi-
tions, the opposite will be true under rapidly changing
conditions (e.g., adaptation to a new mammalian host
or a new arthropod vector). Variants at the periphery
of the quasispecies mutant distribution (i.e., those
most distantly-related to the previous master
sequence) will usually offer the best opportunity for
rapid adaptation to the new conditions. Selected
peripheral variants from the previous mutant distribu-
tion will frequently also be peripheral variants in the
new distribution as the quasispecies moves through
sequence space to optimize adaptability in the new
environment and generate new master sequences. The
very essence of the quasispecies theory of Eigen,
Biebricher and colleagues (12,24±27) is the broad
reach through sequence space which is provided by
RNAvirus replicase error rates poised at the threshold
of error catastrophe. Finally, it should be noted that, as
in all evolution, rapid emergences of new RNA
variants are counterbalanced by rapid extinctions of
others.
Extremely High Mutation Rates Do NotNecessitate Rapid Evolution
Although, it is intuitively obvious that high rates of
RNA virus mutation facilitate rapid evolution, it
seems counterintuitive that RNA viruses sometimes
can exhibit rather long periods of relative evolu-
tionary stasis. In general, RNA viruses evolve rapidly
but rates can vary considerably, and relative stasis is
not uncommon. For example, evolutionary rates for
many RNA viruses can be as high as 10ÿ 2 to 10ÿ 3
base substitutions per nucleotide site per year
(1,6,18,20±23), but rates of evolution of arthropod-
borne viruses can be orders of magnitude slower.
Transovarial passage of the Phlebovirus toscana virus
in sand¯y vectors showed extreme genome stability
during 2 years transmission time and over 12 sand¯y
generations (28). Likewise, alphaviruses in the eastern
equine encephalitis complex evolved at rates nearly as
low as 10ÿ 4 base substitutions ®xed per site per year
(29,30). This low rate of evolution occurred despite
normally high rates of mutation and was attributed to
stabilizing selection for the ability to replicate
ef®ciently in two very disparate hosts; vertebrates
and invertebrate insects (31). Despite this relatively
slow rate of evolution, alphaviruses such as eastern
equine encephalitis virus (and other arboviruses)
undergo signi®cant evolutionary change over the
centuries. For example, it was estimated that the
North and South American antigenic varieties of
eastern equine encephalitis virus diverged about 1000
years ago and the two South American groups
diverged about 450 years ago (30). Venezuelan and
eastern equine encephalitis alphavirus complexes
diverged about 1400 years ago (30) while the Old
and New World alphavirus groups diverged roughly
2000 to 3000 years ago (32). Even today, new
epidemic/epizootic strains of Venezuelan encephalitis
emerge from enzootic strains in South America by
rather minor mutational change (33). Finally, the
western equine encephalitis group was estimated to
have emerged more than 1000 years ago (before the
North and South American equine encephalitis virus
divergence) by a very rare recombination event
between eastern equine encephalitis virus and a
sindbis virus-like progenitor (6,18,34).
Another example of slow versus rapid evolution
can be observed with vesicular stomatitis virus (VSV)
in both laboratory and natural settings. VSV Indiana
serotype has been observed to undergo extremely
rapid evolution under conditions of persistent infec-
tion in cell culture and relative genomic stasis under
conditions of repeated dilute passages in the same
cells (35). In nature, VSV in its enzootic focus in
Panama has undergone very little evolution over
recent decades (36). In contrast extensive evolution
was observed for strains isolated farther north. The
farther north the strains were isolated, the greater was
the sequence diversity from the genetically stable
( presumed ancestral) strains in enzootic foci in
Panama and Costa Rica (36). The greatest divergence
was found in strains from the extreme northern range
of VSV in the United States. Thus, there is a
geographic clock rather than a molecular clock as
would be expected from neutral evolutionary theory.
This apparent punctuated equilibrium evolution was
postulated to be due to different selective ecological
factors operating to drive virus evolution in diverse
geographic areas and different insect vector/hosts are
probably important among these (36). These extre-
mely unequal rates of evolution within a single virus
species and serotype dramatically con®rm the role of
selection in driving virus evolution. They also
Origin and Evolution of Viruses 15
dramatically emphasize the fact that high (and
probably rather constant) mutation rates can be
consistent with both rapid rates of evolution (mutation
®xation) or with evolutionary stasis. Relative stasis
(equilibrium) is favored under more constant selective
conditions in the environment-precisely as is pre-
dicted by quasispecies theory (see section above).
Another remarkable example of a single virus
species exhibiting either evolutionary stasis or
extremely rapid evolution is provided by the thorough
extensive studies of Webster and coworkers (20,37±
39) of in¯uenza virus in natural avian hosts or in
mammalian hosts including humans. In aquatic wild
birds, in¯uenza virus is apparently completely-
adapted to intestinal replication and shedding with
no signs of disease and with very little selection for
evolutionary change. Rapid evolution is the norm
when in¯uenza viruses emerge into mammalian hosts
(20,37,38). Immunity and other selective factors
apparently drive the extreme rates of in¯uenza virus
evolution exhibited during adaptation to mammals.
Overall, the work of Webster and colleagues indicates
that ducks and other waterfowl are the original hosts
for in¯uenza viruses. Rare genome segment reassort-
ment events or transfers of entire in¯uenza virus
genomes initiate emergence into mammalian species,
but it is the destabilizing selective forces in mammals
which drives the ensuing rapid evolution. This is
another good example of punctuated equilibrium in
virus evolution. There are theoretical reasons (based
upon expected movements between adaptive peaks in
adaptive landscapes) to expect that evolution will
frequently exhibit punctuated equilibrium (40). Plant
viruses, such as the tobamoviruses can also exhibit
genetic stability for long periods, again due to strong
environmental selective pressures restricting quasis-
pecies diversi®cation (41).
Effects of Virus Population Transmission Size onSelection, Fitness and Evolution
Whenever viruses become extremely-well-adapted to
host environments and evolutionary stasis is reached,
this equilibrium obviously can be upset readily
( punctuated) by host or vector switching or by drastic
environmental changes. Another, less obvious
mechanism involves changes in the size (dose) of
virus particle transmission. In 1964, Muller (42)
postulated that whenever mutation rates are high and
populations are small in asexual populations, there
can be an inexorable accumulation of deleterious
mutations leading to a ratchet-like decline in
replicative ®tness. Chao (43) convincingly demon-
strated the operation of Muller's ratchet in the
tripartite RNA bacteriophage f6. Chao et al. (44)
also showed that sexual crossing could often reverse
the effects of Muller's ratchet. Quantitation of ®tness
losses during repeated small population transfers
( plaque-to-plaque genetic bottleneck transmissions)
of VSV and food-and-mouth disease virus con®rmed
that variable, stochastic, often-profound ®tness
decreases occur rather regularly (45±49). Clearly,
genetic bottlenecks have the capacity to disturb virus
adaptive equilibrium and thereby to drive stochastic
evolutionary changes. The number of virus particles
which constitute an effective genetic bottleneck can
vary greatly from only several particles to tens of
particles depending upon initial virus population
®tness (50,51).
The opposite effect on ®tness occurs during
repeated transfers of very large numbers (105 to 106)
of infectious virus particles. Under these large dose
transmission conditions, regular exponential increases
in virus replicative ®tness occur and previous ®tness
decreases due to Muller's ratchet are reversed
(48,50,51). Unquestionably, virus population trans-
mission size can affect virus evolution very
profoundly, and this inevitably must also occur
during natural virus outbreaks. Transmission of large
doses of infectious virus particles often occurs during
transmissions involving close contact (e.g., sexual,
kissing); during transfusions or other medical/dental
blood/tissue transmission; intravenous drug abuse,
some insect vector or animal bite transmissions; and
during some very close respiratory droplet transmis-
sions, some fecal-oral transmissions, etc. Genetic
bottleneck transmissions inevitably occur during
many rather distant virus transmissions during
respiratory droplet inhalations. This is clear from
quantitative studies of both experimental and natural
virus aerosol transmissions (52±54). After sneezing
and coughing of infected people in a room, the volume
of room air which must be sampled to obtain a single
infectious particle can be very large (53,54). For
example, 15 men in bed infected with adenovirus type
4 and coughing frequently in a barracks room led to
recovery of one tissue culture infective unit per 2820
sq. ft. (54). Thus, genetic bottleneck transmissions
must be frequent and unavoidable for respiratory
16 Holland and Domingo
viruses although large population transfers must also
occur often during close contact. Similar considera-
tions apply to fecal-oral spread, spread from
inanimate objects (fomites) and from insect vector
transmissions (55). Whenever large virus population
transmissions occur repeatedly, selection can operate
repeatedly to select the best of the best of the best . . .
in terms of virus ®tness in a constant host species.
Conversely, repetitive genetic bottleneck transmis-
sions interrupt selective forces and allow stochastic
changes in ®tness and in evolutionary directions.
These stochastic changes will usually be in the
direction of ®tness loss (and perhaps loss of virulence)
but rarely, by chance, the converse will be true.
Virulence is a multifactorial, multigenic trait which
may or may not correlate with replicative ®tness and
transmission ef®ciency. The major insight to be
gained from experimental studies of virus ®tness is
that RNA viruses are phenotypically quasispecies as
well as genetic quasispecies. Thus, all phenotypic
characteristics, including virulence, will be highly
variable among the numerous mutants present in a
complex quasispecies swarm. Therefore, chance
sampling events such as genetic bottlenecks may
profoundly affect virulence traits (and other traits)
during an epidemic. Likewise, repetitive large
population transmissions can preserve and enhance
virulence or other traits which had been sampled by
chance during earlier genetic bottleneck events. This
can, of course, in¯uence disease severity and outcome
in infected individuals and in small local host cohorts
infected by such sampling of the quasispecies swarm.
Recombination, Reassortment and GeneDuplication in Virus Evolution
As outlined in the chapters on virus origins,
recombination has long been recognized as a central
mechanism in the evolution of DNA bacteriophages
and/or DNA viruses and retroviruses of animals and
plants. Recombination with, and insertion into, and
excision from, cellular DNA allows intimate genetic
interactions with host genomes, episomes and
plasmids. Just as the frequent acquisition of cellular
genes can help shape virus evolution, so can the
frequent acquisition of virus and retroelement genes
help to shape host evolution. A remarkable example is
provided by maize in which many dozens or even
many hundreds of diverse retroelement families
account for 50% or more of the plants nuclear
DNA! Large blocks of reiterated retrotransposons
inserted within each other are found in gene-
containing regions as intergenic segments (56,57).
Clearly, these are involved in determining gene
expression, genome size and genome organization,
so that the distinction between host and sel®sh
parasitic genes is blurred beyond recognition.
Although RNA riboviruses cannot interact with
host DNA genomes as directly, nor as frequently as do
DNA viruses and retroviruses/retroelements, RNA
recombination is equally common and important
among them as evolutionary events. The mechanisms
and importance of recombination in riboviruses and
retroviruses are reviewed in (58,59). Riboviral RNA
recombines with both cellular and viral RNAs and
acquisition of genes and gene segments from both can
be very important in ribovirus evolution and
emergence. Homologous recombination occurs fre-
quently during every replication of most positive
sense riboviruses (58,60) but is extremely rare among
negative sense riboviruses in which non-homologous
recombination events usually generate defective
genomes (some quite bizarre), most of which are
dependent upon non-defective helper viruses for
replication (61). Very rarely, helper-dependent,
bizarre, defective RNA virus genomes are probably
involved in major virus evolutionary events via RNA
recombination with non-defective helper viruses.
Because their helper viruses provide all vital
replication functions, defective viral genomes are
largely unconstrained by selective forces and can
undergo extremely rapid, massive evolution. Thus,
they could (very rarely) donate extensively-mutated
and rearranged genome segments back to the helper
viruses from which they arose (61).
Among the segmented-genome viruses, reassort-
ment of segments provides a ready mechanism for
generating new viruses. The best-known examples, of
course, involve the periodic antigenic shifts of
in¯uenza A viruses which usually occur at multi-
decade intervals to initiate new human pandemics
(37±39). The gene segment reassortment events which
cause emergence of new in¯uenza A viruses are very
rare events because only certain permutations of avian
and mammalian gene segments will be highly
infectious and ®t, and because reassortment requires
rare dual infection (by appropriate progenitor viruses)
of appropriate mixing vessel hostsÐmost often
probably swine or humans (37±39). Once a ®t new
Origin and Evolution of Viruses 17
reassortant emerges into the human population very
rapid evolution ensues (37±39). Reassortment events
are important in the evolution of many other
segmented genome RNA viruses. For example,
bunyaviruses can evolve by reassortment in doubly-
infected mosquitoes (62) and naturally-occurring Sin
Nombre hantavirus reassortants have been observed
in Peromyscus deer mice in Nevada and Eastern
California (63). No reassortants were observed
between Sin Nombre and other hantaviruses indi-
genous to their region, suggesting that reassortants
between distantly-related hantaviruses are rare or non-
viable, and/or that host species speci®cities greatly
limit reassortment. Again, generation of ®t reassor-
tants between distantly-related and different-host-
adapted virus strains is generally a rare event in
nature.
A major mechanism observed in the evolution of
all life formsÐgene duplicationÐis sometimes
important in virus evolution. For example, beet
yellows virus, a ®lamentous RNA virus, contains a
coat protein gene duplication (64) and two rabies-
related rhabdoviruses, Adelaide river virus (65) and
bovine ephemeral fever virus (66) each contain two
consecutive glycoprotein genes of differing size and
sequence. Both glycoprotein genes are expressed in
each of these viruses; via monocistronic mRNAs in
the case of bovine ephemeral fever virus and
polycistronic mRNAs for Adelaide virus. Gene
duplication of this kind occurs by recombination
events, probably via intra- or inter-molecular copy
choice replicase leaps (58,67).
Finally, a very simple, effective mechanisms for
creation of new virus gene products involves acquired
usage of alternative reading frames of an existing gene
to create overlapping genes. This overprinting
mechanism is common in virus evolution as outlined
in the review of Gibbs and Kease (4).
Do DNA Viruses Evolve as Quasispecies?
DNA viruses generally do not form complex
quasispecies mutant swarms to the extent that RNA
viruses do because they generally have genomic
mutation rates about 300-fold lower than those of
RNA riboviruses and roughly 30-fold lower than
retroviruses (23,68). Proofreading and mismatch
repair (69) of DNA can provide ®delity for even
very large DNA virus genomes. Hence, DNA viruses
generally evolve to achieve and maintain optimal
function. They often tend to produce inapparent and
silent latent infections, to co-evolve slowly with their
hosts over geologic time periods, and even to
in¯uence the evolution of their host species (68,70±
73). Nevertheless, many DNA viruses can exhibit
considerable genetic plasticity (74) and this can be
manifested via antiviral drug resistance and other
clinical problems. This is not surprising because DNA
viruses can have host recombination systems avail-
able to them in addition to intrinsic viral mechanisms.
Also, DNA ®delity is limited for viruses which
replicate via single-stranded DNA because mismatch
repair/excision repair systems are unavailable for
single-stranded DNA genomes. But, even bacter-
iophage T7, a classic double-stranded DNA virus
exhibited rapid evolution of replicating ®tness in
single plaques (75). It should be noted that some DNA
viruses such as the canine/feline parvoviruses evolve
in nature at least as rapidly as the slower-evolving
RNA viruses and can change host species speci®cities
very readily as well (76). This is in marked contrast to
the primate papillomaviruses, for example. Van Ranst
et al. (77) estimated primate papillomavirus mutation
rates to be of the order of 3� 10ÿ 8 base substitutions
per site per year in the EG gene. This is only about 20±
30 times faster than the rate of evolution of their
primate host species and about a million-fold lower
than rates of evolution of the most rapidly evolving
RNA riboviruses (29±35,78).
Implications of RNA Virus Quasispecies forDisease and Disease Emergence
Some investigators have stated that quasispecies
mutant swarms are not really necessary for disease
processes during RNAvirus infections. Of course, this
could be argued quantitatively in terms of the minimal
mutation rate which quali®es to produce a quasis-
pecies. However, this misses the essence of RNAvirus
biology. RNA viruses have been the most abundant
and successful parasites since the appearance of
cellular life (see the ®rst chapter) and this has been
achieved by maintaining error rates very near the error
threshold (12). This allows maximal variability and
adaptability (21±27) This great adaptability allows
®tness to be increased rapidly in changing environ-
ments and the intact animal, human, plant or insect
vector organism always confronts invading microbes
18 Holland and Domingo
with multiple, challenging and changing environ-
ments. RNA virus quasispecies frequently undergo
major or minor changes in composition in response to
in¯ammatory and immune responses (20,37,38,79) to
different host cell types within individual infected
organisms, to widely differing conditions in verte-
brate versus insect vector hosts (80), to antiviral drug
treatments (81,82), to inadequate vaccine programs,
etc. Different subsets of the lymphocytic choriome-
ningitis virus quasispecies swarm are involved in
lymphoid cell infection with immune suppression as
contrasted with neuronal cell infection with runting
syndrome (growth hormone de®ciency syndrome)
(83,84).
Perhaps the involvement of quasispecies in disease
is best illustrated by the propensity of polioviruses to
cause paralytic disease in a small percentage of
infected individuals (60), and for some Coxsackie
viruses to cause cardiomyopathy in a small percentage
of infected humans. Microevolution of the quasis-
pecies population present in the type 3 Sabin oral
poliovirus vaccine seed stocks (85) can cause
paralytic disease in a very small percentage of vaccine
recipients and can even initiate outbreaks of polio-
myelitis in unvaccinated populations (60,86). Clearly,
the quasispecies nature of the vaccine seed stocks and
of their progeny is responsible for this rare but
unfortunate disease complication of an otherwise
excellent vaccine. An endemic cardiomyopathy
affecting thousands in China has been associated
with both selenium de®ciency and isolation of
Coxsackieviruses from patients (87,88). Beck et al.
in a remarkable study of selenium de®cient mice (89)
showed that infection by a normally non-virulent
clone of Coxsackie B3 virus induced signi®cant
myocarditis in the Se-de®cient mice, and virus
recovered from the hearts of these myocarditic mice
regularly caused myocarditis in normal Se-adequate
mice! Complete sequence analysis of the recovered
myocarditic strain of Coxsackievirus B3 revealed six
speci®c nucleotide changes, all of which had appeared
in four separate isolates from the initial myocarditic
mouse examined and from 3 individual follow-up
mice (89). This study agrees with the sequence studies
of Chapman et al. (90) who also found that speci®c
changes at these six nucleotide sites are associated
with the cardiovirulent phenotype (89,90) of
Coxsackievirus B3. Nothing could more clearly
illustrate the importance of quasispecies mutant
swarms in RNA virus disease. It is important to
remember that myocarditis due to Coxsackie viruses
is rare relative to the number of human infections.
Virulence is a trait which is seldom selected except
when it correlates with replicative ®tness. Immune
de®cits arising from selenium de®ciency regularly
allowed expansion of the Coxsackievirus B3 quasis-
pecies mutant swarm and colonization of myocardial
cells to cause disease. The cardiovirulent variants
selected in heart muscle cells established a new
quasispecies distribution which was cardiovirulent for
normal mice after it was deliberately isolated from the
total whole animal wild type quasispecies swarm. It is
beyond question in this outstanding study that it is
those quasispecies subsets normally buried within the
total circulating quasispecies population which have
the potential to cause viral myocarditis (89,90). This is
likely a rather typical situation with regard to RNA
virus disease potential.
Finally, the role of RNA virus quasispecies in
future emerging diseases of humans, domestic
animals and crops is obvious. Most emerging human
diseases in recent years have been RNA virus
diseases; from AIDS to Ebola hemorrhagic fever to
hantavirus pulmonary syndrome. Most new or
emergent virus diseases in the future will also be
RNA viruses because of the rapid evolution potential
of their quasispecies. This trend will be accelerated so
long as the human population continues to expand
exponentially. For example, the recent rapid growth of
human populations in tropical areas has been matched
by an equally-rapid increase in dengue fever, dengue
hemorrhagic fever and dengue shock syndrome, and
by an increasing rate of evolution of dengue viruses
(91±93). All of us and our domestic animals (94) are
potential incubators for the rapid exploration of
previously-unexplored sequence space by evolving
RNA viruses. Sequence space is a v-dimensional
hypercube in which v is the genome length in bases or
base pairs (12). For a 10 kb RNA virus genome there
are 410,000 sequence permutations and combinations
which must be explored before all viable and adaptive
virus sequences have been testedÐeven if we assume
a constant genome size restriction (which never
happens). There is not enough space-time in countless
imaginable universes to test even a minuscule fraction
of such incomprehensibly vast dimensions. Hence,
new sequence spaces will be explored increasingly
rapidly in future decades. New RNA viruses and
new diseases will emerge with increasing rapidity as
long as human population growth remains in an
Origin and Evolution of Viruses 19
exponential phase. Planet earth has a ®nite human
carrying capacity, but its dimensions are uncertain and
will be affected by human choices concerning quality
of life, economics, environmental values, etc. (95).
But beyond human choice are the evolutionary paths
to be followed by exponentially-increasing quasispe-
cies swarms of RNA viruses exploring humans as
hosts. Virus evolution is stochastic and unpredictable
(35,96), but increasing numbers of human outbreaks
are inevitable. They will occur; they should be
anticipated and there should be reasonable preparation
for some unpleasant outbreaks. The human carrying
capacity of our planet may ultimately be determined,
not by human choice, but by RNA virus evolution.
Acknowledgments
Work in La Jolla, CA was supported by NIH Grant
AI14627 and in Madrid, Spain by Grants DGICYT PB
94-0034-C02-01, FIS 95/0034-1, Fundacion
Rodriguez Pascual, Communidad Autonima de
Madrid, and Fundacion Ramon Areces.
References
1. Holland J.J. in Mahy B. (ed.), Topley and Wilson'sMicrobiology and Microbial Infections. Arnold, London,
1997, in press.
2. Gorbalenya A.E. in Gibbs A.J., Calisher C.H., and GarcõÂa-
Arenal F. (eds), Molecular Basis of Virus Evolution. Cambridge
University Press, Cambridge, 1995, pp. 49±66.
3. McGeoch D.J. and Davison A.J. in Gibbs A.J., Calisher C.H.,
and GarcõÂa-Arenal F. (eds), Molecular Basis of Virus Evolution.
Cambridge University Press, Cambridge, 1995, pp. 67±75.
4. Gibbs A.J. and Keese P.K. in Gibbs A.J., Calisher C.H., and
GarcõÂa-Arenal F. (eds), Molecular Basis of Virus Evolution.
Cambridge University Press, Cambridge, 1995, pp. 76±90.
5. Meyers G., Tautz N., and Theil H.-J. in Gibbs A.J., Calisher
C.H., and GarcõÂa-Arenal F. (eds), Molecular Basis of VirusEvolution. Cambridge University Press, Cambridge, 1995,
pp. 91±102.
6. Strauss J.H. and Strauss E.G., Microbiol Rev 58, 491±562,
1994.
7. Shapiro J.A., Mobile Genetic Elements, Academic Press, New
York, 1983.
8. Doolittle R.F. and Feng D.F., Curr Top Microbiol Immunol 176,
195±211, 1992.
9. McClure M.A. in Gibbs A.J., Calisher C.H., and GarcõÂa-Arenal
F. (eds), Molecular Basis of Virus Evolution. Cambridge
University Press, Cambridge, 1995, pp. 404±415.
10. Temin H.M., Perspect Biol Med 14, 11±26, 1970.
11. Botstein D. in Fields B.N., Jaenisch R., and Fox C.F. (eds),
Animal Virus Genetics. Academic Press, New York, 1981,
pp. 363±384.
12. Eigen M. and Biebricher C.K. in Domingo E., Holland J.J., and
Ahlquist P. (eds), RNA Genetics. CRC Press, Inc., Boca Raton,
1988, pp. 211±245.
13. Kaufmann S.A., The Origins of Order. Self Organization andSelection in Evolution. Oxford University Press, New York,
1993.
14. Gesteland R.F. and Atkins J.F. (ed.), The RNA World, Cold
Spring Harbor Lab Press, Plainview, NY, 1993.
15. Robertson H.D. in Holland J.J. (ed.), Genetic Diversity of RNAViruses. Curr. Top. Microbiol. Immunol., 1992.
16. Brazas R. and Ganem D., Science 274, 90±94, 1996.
17. Robertson H.D., Science 274, 66±67, 1996.
18. Strauss J.H. and Strauss E.G., Annu Rev Microbiol 42, 657±
683, 1988.
19. Zimmern D. in Domingo E., Holland J.J., and Ahlquist P. (eds),
RNA Genetics. CRC Press, Boca Raton, 1988, pp. 211±240.
20. Webster R.G., Bean W.J., Gorman O.T., Chambers T.M., and
Kawaoka Y., Microbiol Rev 56, 152±179, 1992.
21. Domingo E. and Holland J.J. in Morse S. (ed.), EmergingViruses. Oxford University Press, 1994, pp. 203±218.
22. Domingo E. and Holland J.J., Annu Rev Microbiol, 1997, in
press.
23. Drake J.W., Proc Natl Acad Sci USA 90, 4171±4175, 1993.
24. Domingo E., Holland J.J., Biebricher C., and Eigen M. in
Gibbs A., and Calisher C.H. (eds), Molecular Basisof Virus Evolution. Cambridge University Press, 1995,
pp. 181±191.
25. Eigen M., Naturwissenschaften 58, 65±523, 1971.
26. Eigen M., McCaskill J., and Schuster P., J Phys Chem 92, 6881±
6891, 1988.
27. Rohde N., Daum H., and Biebricher C.K., J Mol Biol 249, 754±
762, 1995.
28. Bilsel P.A., Tesh R.B., and Nichol S.T., Virus Res 11, 87±94,
1988.
29. Weaver S.C., Scott T.W., and Rico-Hesse R., Virology 182,
774±784, 1991.
30. Weaver S.C., Hagenbaugh A., Bellew L.A., Gousset L.,
Mallampalli V., Holland J.J., and Scott T.C., J Virol 68, 158±
169, 1994.
31. Weaver S.C., Rico-Hesse R., and Scott T.W., Curr Top
Microbiol Immunol 176, 99±117, 1992.
32. Weaver S.C., Hagenbaugh A., Bellew L.A., Neteson S.V.,
Volchkov V.E., Chang G.J., Clarke D.K., Gousset L., Scott
T.W., Trent D.W., and Holland J.J., Virology 197, 375±390,
1993.
33. Rico-Hesse R., SC S.C.W., de Siger J., Medina G., and Salas
R.A., Proc Natl Acad Sci USA 92, 5278±5281, 1995.
34. Weaver S.C. in Gibbs A.J., Calisher C.H., and GarcõÂa-Arenal F.
(eds), Molecular Basis of Virus Evolution. Cambridge
University Press, Cambridge, 1995, pp. 501±530.
35. Steinhauer D.A., de la Torre J.C., Meier E., and Holland J.J.,
J Virol 63, 2072±2080, 1989.
36. Nichol S.T., Rowe J.E., and Fitch W.M., Proc Natl Acad Sci
USA 90, 10424±10428, 1993.
37. Webster R.G., Bean W.J., and Gorman O.T. in Gibbs A.J.,
Calisher C.H., and GarcõÂa-Arenal F. (eds), Molecular Basis ofVirus Evolution. Cambridge University Press, Cambridge,
1995, pp. 531±543.
20 Holland and Domingo
38. Gorman O.T., Bean W.J., and Webster R.G., Curr Top
Microbiol Immunol 176, 75±97, 1992.
39. Horimoto T., Rivera E., Pearson J., Senne D., Krauss S.,
Kawaoka Y., and Webster R.G., Virology 213, 223±230, 1995.
40. Newman C.M., Cohen J.E., and Kipnis C., Nature 315, 400±
401, 1985.
41. Fraile A., Aranda M.A., and GarcõÂa-Arenal F. in Gibbs A.J.,
Calisher C.H., and GarcõÂa-Arenal F. (eds), Molecular Basis ofVirus Evolution. Cambridge University Press, Cambridge,
1995, pp. 338±350.
42. Muller H.J., Mutation Res 1, 2±9, 1964.
43. Chao L., Nature 348, 454±455, 1990.
44. Chao L., Tran T.R., and Matthews C., Evolution 46, 289±299,
1992.
45. Duarte E., Clarke D., Moya A., Domingo E., and Holland J.,
Proc Natl Acad Sci USA 89, 6015±6019, 1992.
46. Duarte E.A., Clarke D.K., Moya A., Elena S.F., Domingo E.,
and Holland J., J Virol 67, 3620±3623, 1993.
47. Duarte E., Novella I.S., Ledesma S., Clarke D.K., Moya A.,
Elena S.F., Domingo E., and Holland J.J., J Virol 68, 4295±
4301, 1994.
48. Clarke D., Duarte E., Moya A., Elena S., Domingo E., and
Holland J.J., J Virol 67, 222±228, 1993.
49. Escarmis C., DaÂvila M., Charpentier N., Bracho A., Moya A.,
and Domingo E., J Mol Biol 264, 255±267, 1996.
50. Novella I.S., Elena S.F., Moya A., Domingo E., and Holland
J.J., J Virol 69, 2869±2872, 1995.
51. Novella I.S., Duarte E.A., Elena S.F., Moya A., Domingo E.,
and Holland J.J., Proc Natl Acad Sci USA 92, 5841±5844,
1995.
52. Couch R.B., Cate T.R., Douglas R.G., Jr., Gerone P.J., and
Knight V., Bacteriol Rev 30, 517±529, 1966.
53. Gerone P.J., Couch R.B., Keefer G.V., Douglas R.G.,
Derrenbacher E.B., and Knight V., Bacteriol Rev 30, 576±
584, 1966.
54. Artenstein M.S. and Miller W.S., Bacteriol Rev 30, 571±572,
1966.
55. Weaver S.C., Scott T.W., and Lorenz L.H., J Med Entomol 27,
878±891, 1990.
56. San Miguel P., Tikhonov A., Jin J.K., Motchoulskaia N.,
Zakharov D., Melake-Berhan A., Springer P.S., Edwards K.J.,
Lee M., Avramova Z., and Bennetzen J.L., Science 274, 765±
768, 1996.
57. Voytas D.F., Science 274, 737±738, 1996.
58. Lai M.M.C., Curr Top Microbiol Immunol 176, 21±32, 1992.
59. Cof®n J.H., Curr Top Microbiol Immunol 176, 143±164, 1992.
60. Wimmer E., Hellen C.U.T., and Cao X., Annu Rev Genet 27,
353±435, 1993.
61. Holland J.J. in Fields B.N., and Knipe D.M. (eds), FieldsVirology. Raven Press, New York, 1990, pp. 151±165.
62. Beaty B.J., Sundin D.R., Chandler L.J., and Bishop D.H.,
Science 230, 548±550, 1985.
63. Henderson W.W., Monroe M.C., St. Jeor S.C., Thayer W.P.,
Rowe J.E., Peters C.J., and Nichol S.T., Virology 214, 602±610,
1995.
64. Boyko V.P., Karasev A.V., Agranovsky A.A., Koonin E.V., and
Dolja V.V., Proc Natl Acad Sci USA 89, 9156±9160, 1992.
65. Wang Y. and Walker P.J., Virology 195, 719±731, 1993.
66. Walker P.J., Byrne K.A., Riding G.A., Cowley J.A., Wang Y.,
and McWilliam S., Virology 191, 49±61, 1992.
67. Perrault J., Curr Top Microbiol Immunol 93, 151±207, 1981.
68. Drake J.W., Proc Natl Acad Sci USA 88, 7160±7164, 1991.
69. Loeb L.A. and Kunkel T.A., Annu Rev Biochem 52, 429±457,
1982.
70. Biggar R.J., Taylor M.E., Neel J.V., Hjelle B., Levine P.H.,
Black F.L., Shaw G.M., Sharp P.M., and Hahn B.H., Virology
216, 165±173, 1996.
71. Harwood S.H. and Beckage N.E., Insect Biochem Mol Biol 24,
685±698, 1994.
72. Ho L., Chan S.Y., Burk R.D., Das B.C., Fujinaga K., Icenogle
J.P., Kahn T., Kiviat N., Lancaster W., Mavromara-Nazos P.,
and et al., J Virol 67, 6413±6423, 1993.
73. Shadan F.F. and Villarreal L., Virus Genes 11, 239±257, 1996.
74. Smith D.B. and Inglis S.C., J Gen Virol 68, 2729±2740, 1987.
75. Lee Y. and Yin J., Nat Biotech 14, 491±493, 1996.
76. Truyen U., Evermann J.F., Vieler E., and Parrish C.R., Virology
215, 186±189, 1996.
77. Van Ranst M., Kaplan J.B., Sundberg J.P., and Burk R.D. in
Gibbs A.J., Calisher C.H., and GarcõÂa-Arenal F. (eds),
Molecular Basis of Virus Evolution. Cambridge University
Press, Cambridge, 1995, pp. 455±476.
78. Sanchez A., Trappier S.G., Mahy B.W., Peters C.J., and Nichol
S.T., Proc Natl Acad Sci USA 93, 3602±3607, 1996.
79. Domingo E., Diez J., MartõÂnez M.A., HernaÂndez J., HolguõÂm
A., Borrego B., and Mateu M.G., J Gen Virol 74, 2039±2045,
1993.
80. Novella I.S., Clarke D.K., Quer J., Duarte E.A., Lee C., Weaver
S., Elena S.F., Moya A., Domingo E., and Holland J.J., J Virol
69, 6805±6809, 1995.
81. NaÂjera I., HolguõÂn A., Quinones-Mateu M.E., MunÄoz-
Fernandez M.A., NaÂjera R., Lopez-Galindez C., and Domingo
E., J Virol 69, 23±31, 1995.
82. Havlir D.V., Eastman S., Gamst A., and Richman D.D., J Virol
70, 7894±7899, 1996.
83. Dockter J., Evans C.F., Tishon A., and Oldstone M.B.A., J Virol
70, 1799±1803, 1996.
84. Teng M.N., Oldstone M.B.A., and de la Torre J.C., Virology
223, 113±119, 1996.
85. Rezapkin G.V., Norwood L.P., Taffs R.E., Dragunsky E.M.,
Levenbock I.S., and Chumakov K.M., Virology 211, 377±384,
1995.
86. Kew O., Nottay M.B.K., Hatch M.H., Nakano J.H., and
Obijeski J.F., J Gen Virol 56, 337±347, 1981.
87. Gu B.Q., Chin Med J 96, 251±261, 1983.
88. Su C., Chin Med J 59, 466±472, 1979.
89. Beck M.A., Shi Q., Morris V.C., and Levander O.A., Nature
Med 1, 433±436, 1995.
90. Chapman N.M., Tu Z., STracy, and Gauntt C.J., Arch Virol 135,
115±130, 1994.
91. Monath T.P., Proc Natl Acad Sci USA 91, 2395±2400, 1994.
92. Holland J.J., Proc Natl Acad Sci USA 93, 545±546, 1996.
93. Zanotto P.M., Gould E.A., Gao G.F., Harvey P.H., and Holmes
E.C., Proc Natl Acad Sci USA 93, 548±553, 1996.
94. Guan Y., Shortridge K.F., Krauss S., Li P.H., Kawaoka Y., and
Webster R.G., J Virol 70, 8041±8046, 1996.
95. Cohen J.E., Science 269, 341±346, 1995.
96. Spindler K.R., Horodyski F.M., and Holland J.J., Virology 119,
96±108, 1982.
Origin and Evolution of Viruses 21